These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 19548591)

  • 1. Minireview: molecular structure and dynamics of drug targets.
    Dahl SG; Sylte I
    Prague Med Rep; 2008; 109(2-3):107-12. PubMed ID: 19548591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Drugs: molecular pharmacology, sites of action and drug receptors].
    Astier A
    Soins; 1984 Oct; (439):13-25. PubMed ID: 6569695
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular electrostatic potential as a factor of drug-receptor recognition.
    Dukhovich FS; Darkhovskii MB
    J Mol Recognit; 2003; 16(4):191-202. PubMed ID: 12898669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flexible drug molecules and dynamic receptors.
    Williams RJ
    Angew Chem Int Ed Engl; 1977 Nov; 16(11):766-77. PubMed ID: 412440
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experimental allergy as a model of pharmacological activity].
    Alonso de Florida F
    Bol Estud Med Biol; 1983; 32(7-8 Suppl 1):53-65. PubMed ID: 6100436
    [No Abstract]   [Full Text] [Related]  

  • 6. Supramolecular chemistry. New synthetic receptors.
    Lindoy LF
    Nature; 1992 Mar; 356(6366):197-8. PubMed ID: 1552938
    [No Abstract]   [Full Text] [Related]  

  • 7. [Receptor occupation theory and its parameter estimates (author's transl)].
    Xu DZ
    Sheng Li Ke Xue Jin Zhan; 1981 Oct; 12(4):318-24. PubMed ID: 7344074
    [No Abstract]   [Full Text] [Related]  

  • 8. Experimental procedure for estimating the dissociation constant of noncompetitive interactants. Part I.
    Orsetti M
    Boll Soc Ital Biol Sper; 1986 Jan; 62(1):51-7. PubMed ID: 3718726
    [No Abstract]   [Full Text] [Related]  

  • 9. [Data for the modeling of drug-receptor interaction, taking into consideration additives or combined active ingredients in the formulation].
    Bozzay J; Békefi E; Dávid A; Rusznák I
    Acta Pharm Hung; 1983 May; 53(3):97-105. PubMed ID: 6880768
    [No Abstract]   [Full Text] [Related]  

  • 10. [Receptors; from idea to reality].
    Ariëns EJ
    Ned Tijdschr Geneeskd; 1983 Jul; 127(28):1235-8. PubMed ID: 6310420
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical chronopharmacology].
    Markiewicz A
    Pol Tyg Lek; 1983 Dec 19-26; 38(51-52):1611-4. PubMed ID: 6687238
    [No Abstract]   [Full Text] [Related]  

  • 12. Fractional description of free energies of solvation.
    Luque FJ; Barril X; Orozco M
    J Comput Aided Mol Des; 1999 Mar; 13(2):139-52. PubMed ID: 10091120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug design by the method of receptor fit.
    Goodford PJ
    J Med Chem; 1984 May; 27(5):558-64. PubMed ID: 6716396
    [No Abstract]   [Full Text] [Related]  

  • 14. [Interaction between the metabolism of drugs: pharmacological aspects].
    von Bahr C; Orrenius S; Sjöqvist F
    Lakartidningen; 1968 Mar; 65():Suppl I:58+. PubMed ID: 5743121
    [No Abstract]   [Full Text] [Related]  

  • 15. [General pharmacodynamic principles].
    Bernard JP; Opdal MS; Khiabani H
    Tidsskr Nor Laegeforen; 2006 Aug; 126(16):2107-9. PubMed ID: 16932780
    [No Abstract]   [Full Text] [Related]  

  • 16. [Drugs and the aged].
    Platt D
    Med Monatsschr Pharm; 1983 Sep; 6(9):269-74. PubMed ID: 6633421
    [No Abstract]   [Full Text] [Related]  

  • 17. Tissue density of drugs with respect to time.
    Booth NH
    J Am Vet Med Assoc; 1980 May; 176(10 Spec No):1134-40. PubMed ID: 7216888
    [No Abstract]   [Full Text] [Related]  

  • 18. Principles of agonism: undressing efficacy.
    Schwartz TW; IJzerman AP
    Trends Pharmacol Sci; 1998 Nov; 19(11):433-6. PubMed ID: 9850604
    [No Abstract]   [Full Text] [Related]  

  • 19. The two-state model of agonist action: challenges to pharmacological receptor theory.
    Leff P
    Proc West Pharmacol Soc; 1996; 39():67-8. PubMed ID: 8895972
    [No Abstract]   [Full Text] [Related]  

  • 20. How should values of pA2 and affinity constants for pharmacological competitive antagonists be estimated?
    MacKay D
    J Pharm Pharmacol; 1978 May; 30(5):312-3. PubMed ID: 26747
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.